Skip to main content
Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy 2/2014

01.02.2014 | Knee

Penetration of topical diclofenac sodium 4 % spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial

verfasst von: Turgay Efe, Ercan Sagnak, Philip P. Roessler, Alan Getgood, Thilo Patzer, Susanne Fuchs-Winkelmann, Christian D. Peterlein, Markus D. Schofer

Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The present study was designed to evaluate the penetration of diclofenac sodium 4 % spray gel in synovial tissue, synovial fluid and blood plasma after topical application in subjects with joint effusions and planned total knee arthroplasty (TKA) due to osteoarthritis.

Methods

A total of 39 patients were randomised to two- or three-times daily application of diclofenac sodium 4 % spray gel to knees requiring surgery over a treatment period of 3 days. Within 8 h after the last application, TKA was conducted, and the diclofenac concentrations in synovial tissue, synovial fluid and blood plasma were measured by liquid chromatography.

Results

The median diclofenac concentration was approximately 10–20-fold higher in synovial tissue (36.2 and 42.8 ng/g) than in synovial fluid (2.6 and 2.8 ng/mL) or plasma (3.9 and 4.1 ng/mL) in both treatment groups. Dose proportionality for any compartment or treatment groups could not be detected. Treatment-related adverse events were noted in two cases and limited to skin reactions.

Conclusion

Diclofenac sodium 4 % spray gel was found to penetrate the skin locally in substantial amounts and thus reach the desired target tissue. Concentrations were not dose-dependent, and application was well tolerated by 97.4 % of patients. Topical application of diclofenac should be considered a valuable alternative to systemic NSAID therapy in the initial treatment of osteoarthritis.
Literatur
1.
Zurück zum Zitat Arcangeli P, Andreotti L, Palazzini E (1996) Effective treatment of osteoarthritis with a 150 mg prolonged-release of diclofenac sodium. Riv Eur Sci Med Farmacol 18(5–6):217–223PubMed Arcangeli P, Andreotti L, Palazzini E (1996) Effective treatment of osteoarthritis with a 150 mg prolonged-release of diclofenac sodium. Riv Eur Sci Med Farmacol 18(5–6):217–223PubMed
2.
Zurück zum Zitat Barron MC, Rubin BR (2007) Managing osteoarthritic knee pain. J Am Osteopath Assoc 107(10 Suppl 6):21–27 Barron MC, Rubin BR (2007) Managing osteoarthritic knee pain. J Am Osteopath Assoc 107(10 Suppl 6):21–27
3.
Zurück zum Zitat Benson MD, Aldo-Benson M, Brandt KD (1985) Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis. Semin Arthritis Rheum 15(2 Suppl 1):65–67PubMedCrossRef Benson MD, Aldo-Benson M, Brandt KD (1985) Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis. Semin Arthritis Rheum 15(2 Suppl 1):65–67PubMedCrossRef
4.
Zurück zum Zitat Brune K (2007) Persistence of NSAIDs at effect sites and rapid disappearance from side effect compartments contributes to tolerability. Curr Med Res Opin 23(12):2985–2995PubMedCrossRef Brune K (2007) Persistence of NSAIDs at effect sites and rapid disappearance from side effect compartments contributes to tolerability. Curr Med Res Opin 23(12):2985–2995PubMedCrossRef
5.
Zurück zum Zitat Brunner M, Dehghanyar P, Seigfried B, Martin W, Menke G, Muller M (2005) Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation. Br J Clin Pharmacol 60(5):573–577PubMedCrossRef Brunner M, Dehghanyar P, Seigfried B, Martin W, Menke G, Muller M (2005) Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation. Br J Clin Pharmacol 60(5):573–577PubMedCrossRef
6.
Zurück zum Zitat Courtney P, Doherty M (2002) Key questions concerning paracetamol and NSAIDs for osteoarthritis. Ann Rheum Dis 61(9):767–773PubMedCrossRef Courtney P, Doherty M (2002) Key questions concerning paracetamol and NSAIDs for osteoarthritis. Ann Rheum Dis 61(9):767–773PubMedCrossRef
7.
Zurück zum Zitat Davies NM, Anderson KE (1997) Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 33(3):184–213PubMedCrossRef Davies NM, Anderson KE (1997) Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 33(3):184–213PubMedCrossRef
8.
Zurück zum Zitat Elmquist WF, Chan KK, Sawchuk RJ (1994) Transsynovial drug distribution: synovial mean transit time of diclofenac and other nonsteroidal antiinflammatory drugs. Pharm Res 11(12):1689–1697PubMedCrossRef Elmquist WF, Chan KK, Sawchuk RJ (1994) Transsynovial drug distribution: synovial mean transit time of diclofenac and other nonsteroidal antiinflammatory drugs. Pharm Res 11(12):1689–1697PubMedCrossRef
9.
Zurück zum Zitat Escribano E, Calpena AC, Queralt J, Obach R, Domenech J (2003) Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci 19(4):203–210PubMedCrossRef Escribano E, Calpena AC, Queralt J, Obach R, Domenech J (2003) Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci 19(4):203–210PubMedCrossRef
10.
Zurück zum Zitat Felson DT, Neogi T (2004) Osteoarthritis: is it a disease of cartilage or of bone? Arthritis Rheum 50(2):341–344PubMedCrossRef Felson DT, Neogi T (2004) Osteoarthritis: is it a disease of cartilage or of bone? Arthritis Rheum 50(2):341–344PubMedCrossRef
11.
Zurück zum Zitat Fowler PD, Shadforth MF, Crook PR, John VA (1983) Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. Eur J Clin Pharmacol 25(3):389–394PubMedCrossRef Fowler PD, Shadforth MF, Crook PR, John VA (1983) Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. Eur J Clin Pharmacol 25(3):389–394PubMedCrossRef
12.
Zurück zum Zitat Hamad M, Metwally S, El-Shafey A, Geneidi A (1994) Comparative percutaneous absorption of diclofenac emulgel penetrations in normal volunteers. J Drug Res 21:133–141 Hamad M, Metwally S, El-Shafey A, Geneidi A (1994) Comparative percutaneous absorption of diclofenac emulgel penetrations in normal volunteers. J Drug Res 21:133–141
13.
Zurück zum Zitat Henry D, Lim LL, Rodriguez LAG, Gutthann SP, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 312(7046):1563–1566PubMedCrossRef Henry D, Lim LL, Rodriguez LAG, Gutthann SP, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 312(7046):1563–1566PubMedCrossRef
14.
Zurück zum Zitat Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M (2003) EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62(12):1145–1155PubMedCrossRef Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M (2003) EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62(12):1145–1155PubMedCrossRef
15.
Zurück zum Zitat Liauw HL, Ku E, Brandt KD, Benson MD, Aldo-Benson MA, Waiter SL, Lee W, Chan K, Vyas K (1985) Effects of Voltaren on arachidonic acid metabolism in arthritis patients. Agents Actions Suppl 17:195–199PubMedCrossRef Liauw HL, Ku E, Brandt KD, Benson MD, Aldo-Benson MA, Waiter SL, Lee W, Chan K, Vyas K (1985) Effects of Voltaren on arachidonic acid metabolism in arthritis patients. Agents Actions Suppl 17:195–199PubMedCrossRef
17.
Zurück zum Zitat Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ (2004) Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord 5:28–35PubMedCentralPubMedCrossRef Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ (2004) Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord 5:28–35PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Miyatake S, Ichiyama H, Kondo E, Yasuda K (2008) Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications. BJCP 67(1):125–129 Miyatake S, Ichiyama H, Kondo E, Yasuda K (2008) Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications. BJCP 67(1):125–129
19.
Zurück zum Zitat Moore RA (2004) Topical nonsteroidal antiinflammatory drugs are effective in osteoarthritis of the knee. J Rheumatol 31(10):1893–1895PubMed Moore RA (2004) Topical nonsteroidal antiinflammatory drugs are effective in osteoarthritis of the knee. J Rheumatol 31(10):1893–1895PubMed
20.
Zurück zum Zitat Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ (1998) Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316(7128):333–338PubMedCrossRef Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ (1998) Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316(7128):333–338PubMedCrossRef
21.
Zurück zum Zitat Nishihata T, Kotera K, Nakano Y, Yamazaki M (1987) Rat percutaneous transport of diclofenac and influence of hydrogenated soya phospholipids. Chem Pharm Bull (Tokyo) 35(9):3807–3812CrossRef Nishihata T, Kotera K, Nakano Y, Yamazaki M (1987) Rat percutaneous transport of diclofenac and influence of hydrogenated soya phospholipids. Chem Pharm Bull (Tokyo) 35(9):3807–3812CrossRef
22.
Zurück zum Zitat Radermacher J, Jentsch D, Scholl MA, Lustinetz T, Frolich JC (1991) Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 31(5):537–541PubMedCrossRef Radermacher J, Jentsch D, Scholl MA, Lustinetz T, Frolich JC (1991) Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 31(5):537–541PubMedCrossRef
23.
Zurück zum Zitat Riess W, Schmid K, Botta L, Kobayashi K, Moppert J, Schneider W, Sioufi A, Strusberg A, Tomasi M (1986) The percutaneous absorption of diclofenac. Arzneimittelforschung 36(7):1092–1096PubMed Riess W, Schmid K, Botta L, Kobayashi K, Moppert J, Schneider W, Sioufi A, Strusberg A, Tomasi M (1986) The percutaneous absorption of diclofenac. Arzneimittelforschung 36(7):1092–1096PubMed
24.
Zurück zum Zitat Sherertz EF, Sloan KB, McTiernan RG (1987) Use of theoretical partition coefficients determined from solubility parameters to predict permeability coefficients for 5-fluorouracil. J Invest Dermatol 89(2):147–151PubMedCrossRef Sherertz EF, Sloan KB, McTiernan RG (1987) Use of theoretical partition coefficients determined from solubility parameters to predict permeability coefficients for 5-fluorouracil. J Invest Dermatol 89(2):147–151PubMedCrossRef
25.
Zurück zum Zitat Taylor RS, Fotopoulos G, Maibach H (2011) Safety profile of topical diclofenac: a meta analysis of blinded, randomized, controlled trials in musculoskeletal conditions. Curr Med Res Opin 27(3):605–622PubMedCrossRef Taylor RS, Fotopoulos G, Maibach H (2011) Safety profile of topical diclofenac: a meta analysis of blinded, randomized, controlled trials in musculoskeletal conditions. Curr Med Res Opin 27(3):605–622PubMedCrossRef
26.
Zurück zum Zitat Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, Dincer F, Dziedzic K, Hauselmann HJ, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Maheu E, Martin-Mola E, Pavelka K, Punzi L, Reiter S, Sautner J, Smolen J, Verbruggen G, Zimmermann-Gorska I (2007) EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66(3):377–388PubMedCrossRef Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, Dincer F, Dziedzic K, Hauselmann HJ, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Maheu E, Martin-Mola E, Pavelka K, Punzi L, Reiter S, Sautner J, Smolen J, Verbruggen G, Zimmermann-Gorska I (2007) EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66(3):377–388PubMedCrossRef
27.
Zurück zum Zitat Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (2007) OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthr Cartil 15(9):981–1000PubMedCrossRef Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (2007) OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthr Cartil 15(9):981–1000PubMedCrossRef
Metadaten
Titel
Penetration of topical diclofenac sodium 4 % spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial
verfasst von
Turgay Efe
Ercan Sagnak
Philip P. Roessler
Alan Getgood
Thilo Patzer
Susanne Fuchs-Winkelmann
Christian D. Peterlein
Markus D. Schofer
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Knee Surgery, Sports Traumatology, Arthroscopy / Ausgabe 2/2014
Print ISSN: 0942-2056
Elektronische ISSN: 1433-7347
DOI
https://doi.org/10.1007/s00167-013-2408-0

Weitere Artikel der Ausgabe 2/2014

Knee Surgery, Sports Traumatology, Arthroscopy 2/2014 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.